Transcatheter Mitral Valve Implantation In Patients With Chronic Kidney Disease

There is a paucity of data regarding the outcomes of trans-septal transcatheter mitral valve implantation (TS-TMVI) in patients with chronic kidney disease (CKD). We queried the Nationwide Readmissions Database (2015 to 2018) for patients undergoing TS-TMVI. We identified patients with CKD (Stage II...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2022-04, Vol.169, p.100-106
Main Authors: Elbadawi, Ayman, Abdelghany, Mahmoud, Dang, Alexander, Omer, Mohamed A., Javaid, Awad I., Eid, Mennallah, Kayani, Waleed T., Paniagua, David, Jneid, Hani
Format: Article
Language:English
Subjects:
Anemia
Cardiovascular disease
Confidence intervals
Coronary vessels
Diabetes
Dialysis
Female
Heart failure
Heart surgery
Heart Valve Prosthesis Implantation - methods
Heart valves
Hemodialysis
Hospital Mortality
Hospitalization
Hospitals
Humans
Implantation
Kidney diseases
Kidneys
Length of stay
Mitral valve
Mitral Valve - surgery
Mortality
Pacemakers
Patients
Renal function
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - epidemiology
Risk Factors
Shock, Cardiogenic - etiology
Subgroups
Thoracic surgery
Transplants & implants
Treatment Outcome
Vein & artery diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is a paucity of data regarding the outcomes of trans-septal transcatheter mitral valve implantation (TS-TMVI) in patients with chronic kidney disease (CKD). We queried the Nationwide Readmissions Database (2015 to 2018) for patients undergoing TS-TMVI. We identified patients with CKD (Stage III or higher). We conducted propensity score matching analysis to compare the outcomes in patients with CKD versus patients without CKD. The main outcomes were in-hospital mortality and 30-day nonelective readmissions. From 2015 to 2018, there were 2,017 admissions for patients receiving TS-TMVI, of whom 733 (36.34%) had CKD. In the CKD group, 76 (10.4%) required chronic dialysis. During the study years, the number of TS-TMVI procedures increased in patients with CKD (ptrend
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2021.12.053